EPID-01. GLIOBLASTOMA TREATMENT OF BEVACIZUMAB ERA IN KANSAI REGION, JAPAN

Randomized trials failed to prove the efficacy of Bevacizumab on OS of newly diagnosed glioblastomas, but improvement of PFS was revealed. Based on these results, Japanese national health insurance approved Bevacizumab (Bev) for both primary and recurrent glioblastoma treatment in 2013. And at same...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Mori, Kanji, Shofuda, Tomoko, Okita, Yoshiko, Arita, Hideyuki, Kinoshita, Manabu, Terakawa, Yuzo, Tsuyuguchi, Naohiro, Tomogane, Yusuke, Fukai, Junya, Ishibashi, Kenichi, Nishida, Namiko, Taki, Takuyu, Nonaka, Masahiro, Izumoto, Shuichi, Moriuchi, Shusuke, Nakajima, Yoshikazu, Hashimoto, Naoya, Kodama, Yoshinori, Hirose, Takanori, Kanemura, Yonehiro
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2017
Onderwerpen:
Abstracts
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5693178/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.279
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items